tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market
Advertisement

Bafna Pharmaceuticals Limited (BAFNAPH) Financial Statements

Compare
0 Followers

Bafna Pharmaceuticals Limited Financial Overview

Bafna Pharmaceuticals Limited's market cap is currently ₹4.14B. The company's EPS TTM is ₹1.433; its P/E ratio is 50.13; Bafna Pharmaceuticals Limited is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 23Dec 22Dec 21Dec 20
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

Bafna Pharmaceuticals Limited Debt to Assets

Bafna Pharmaceuticals Limited Cash Flow

Bafna Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis